#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Glomerulonephritis chronic Complex regional pain syndrome Wolfram syndrome Alpha-1 antitrypsin deficiency Diffuse large B-cell lymphoma refractory Glycogen storage disease type V Metastases to central nervous system Pustular psoriasis Pulmonary fibrosis Aspergillus infection Fatty acid oxidation disorder Diabetes insipidus Central nervous system neoplasm Primary immunodeficiency syndrome Glomerulonephritis More trials…

    Learn about Rare Diseases

    Mucous membrane pemphigoid Hypereosinophilic syndrome – Basic Information Pemphigus – Life with Disease Burkitt’s lymphoma – Trials in Disease Uterine leiomyosarcoma Sjogren’s syndrome – Basic Information Soft tissue sarcoma Factor VIII deficiency – Basic Information Acquired haemophilia – Trials in Disease Mucopolysaccharidosis More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Prednisolone Cefalexin Monohydrate Exenatide DICLOFENAC POTASSIUM Atuliflapon Arachis Hypogaea (762) Vusolimogene Oderparepvec Tamibarotene Lna043 Gsk4527226 Co-Trimoxazole R3R01 Tipiracil Hydrochloride Triamcinolone Hexacetonide Azd9550 Levosimendan T89 Sertindole Abatacept Ilofotase Alfa More therapies…

    Learn about Your Condition

    Major depression White matter lesion Endometrial cancer stage III Macular oedema Anaemia of pregnancy Haemorrhage prophylaxis Brain cancer metastatic Constipation Type 1 diabetes mellitus Endotracheal intubation Pharyngeal cancer stage III Extra-osseous Ewing's sarcoma Thrombosis prophylaxis HER2 negative breast cancer Immune thrombocytopenia More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Lung cancer metastatic

  • Study of Drug Combination with Pembrolizumab Guided by Blood Biomarkers for Patients with Metastatic Non-Small Cell Lung Cancer

    Not yet recruiting

    4 1 1 1
    Investigated Diseases:
    • Lung cancer metastatic
    Investigated Drugs:
    • Pemetrexed Disodium
    • Carboplatin
    • Cisplatin
    Italy

  • Study on the Safety and Effects of ATL001 and Pembrolizumab in Adults with Advanced Non-Small Cell Lung Cancer

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Adenosquamous cell lung cancer recurrent
    • Adenosquamous cell lung cancer stage III
    • Adenosquamous cell lung cancer stage IV
    Investigated Drugs:
    • Atl001
    • Pembrolizumab
    France Germany Spain

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!